n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Lung Diseases, Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, CT; Oliaro, A; Tian, JH; Wang, DL; Wang, NQ | 1 |
| Liu, CT | 1 |
| Coupal, JJ; Dillon, ML; Kung, HF; Shih, WJ | 1 |
1 trial(s) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Clinical application of 131I-HIPDM in the patients with chronic obstructive pulmonary disease.
Topics: Adult; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lung Diseases, Obstructive; Male; Middle Aged; Radionuclide Imaging | 1994 |
2 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Clinical evaluation of the metabolism and imaging of the lung in the patients with chronic obstructive pulmonary diseases using 131I-HIPDM].
Topics: Adult; Aged; Animals; Asthma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lung; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middle Aged; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Smoking | 1992 |
Application of I-123 HIPDM as a lung imaging agent.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Female; Humans; Iodobenzenes; Lung; Lung Diseases, Obstructive; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging | 1988 |